Comment by pama

No it didn’t. At least not for new small molecule drugs. It did reduce times a bit for the first vaccines because there were many volunteers available, and it did allow some antibody drug candidates to be used before full testing was complete. The only approved small molecule drug for covid is paxlovid, with both components of its formulation tested on humans for the first time many years before covid. All the rest of the small molecule drugs are still in early parts of the pipeline or have been abandoned.